Riederer, Peter, 1942-....
Riederer, P. (Peter)
Riederer, Peter.
Riederer, P.
Peter Riederer
Riederer, Peter Franz
Riederer, P. (Peter), 1942-
VIAF ID: 66586945 ( Personal )
Permalink: http://viaf.org/viaf/66586945
Preferred Forms
- 100 0 _ ‡a Peter Riederer
- 200 _ | ‡a Riederer ‡b Peter
-
- 100 1 0 ‡a Riederer, P. ‡q (Peter)
-
- 100 1 _ ‡a Riederer, P. ‡q (Peter)
-
-
-
-
-
-
- 100 1 _ ‡a Riederer, Peter ‡d 1942-
- 100 1 _ ‡a Riederer, Peter ‡d 1942-
-
- 100 1 _ ‡a Riederer, Peter, ‡d 1942-....
-
4xx's: Alternate Name Forms (19)
5xx's: Related Names (2)
Works
Title | Sources |
---|---|
45 years German Society of Biological Psychiatry (DGBP) | |
Advances in research on neurodegeneration, volume 5 | |
Amine oxidases and their impact on neurobiology : proceedings of the 4th International Amine Oxidases Workshop, Würzburg, Federal Republic of Germany, July 7-10, 1990 | |
Basic aspects of receptor biochemistry : proceedings of the international symposium, Vienna, September 10-12, 1982 | |
Biogene Transmitter und Akupunktur | |
Blood-based biomarker in Parkinson’s disease: potential for future applications in clinical research and practice | |
Cognitive impairment in 873 patients with idiopathic Parkinson’s disease Results from the German Study on Epidemiology of Parkinson’s Disease with Dementia (GEPAD) | |
Current topics in extrapyramidal disorders, 1980 (a.e.) | |
Demenz und Depression determinieren Pflegebedürftigkeit bei M. Parkinson Untersuchung an 1449 Patienten im ambulanten Versorgungssektor in Deutschland | |
Depression and care-dependency in Parkinson’s disease: Results from a nationwide study of 1449 outpatients | |
Depression Biochemie, Klinik, Therapie | |
L-Dopa-Substitution der Parkinson-Krankheit Geschichte - Gegenwart - Zukunft | |
Early diagnosis and preventive therapy in Parkinson's disease | |
Focus on extrapyramidal dysfunction | |
Grundlagen der Neuro-Psychopharmakologie : Ein Therapiehandbuch | |
Handbook of Neurochemistry and Molecular Neurobiology : Degenerative Diseases of the Nervous System | |
An Introduction to neurotransmission in health and disease | |
Iron in central nervous system disorders | |
MAO-B-inhibitor selegiline (R-(-)-deprenyl) : a new therapeutic concept in the treatment of Parkinson's disease : proceedings of the international symposium in Berlin, January 23-25, 1987 | |
Modèle de zone adapté aux essais de régulateurs de systèmes de chauffage et de climatisation | |
Monoamine oxidase and its selective inhibitors | |
Morbus Parkinson Selegilin (R-(-)-Deprenyl) ; Movergan ; e. neues Therapiekonzept | |
Neuroprotection in neurodegeneration : [International symposium held in Würzburg on April 21-24 1993] | |
Neurotransmitter und menschliches Verhalten. | |
Oxidative stress and neuroprotection | |
Die Parkinson-Krankheit Grundlagen, Klinik, Therapie | |
Parkinsonmittel und Antidementiva | |
Parkinson's disease and related disorders | |
Parkinson's disease : biochemistry, clinical pathology, and treatment | |
Pathobiology and clinics of basal ganglia disorders | |
Pathochemical markers in major ... 1984: | |
The Role of brain dopamine | |
Understanding the neurotransmitters : key to the workings of the brain | |
Viertes Drei-Länder-Symposium für Biologische Psychiatrie |